# OnCo record trap-btc (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/trap-btc/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "trap-btc", "NCT06178445" ;
  schema:name "TRAP-BTC"@en ;
  schema:description "A small German study giving trastuzumab and pembrolizumab together with standard chemotherapy as the first treatment for HER2-positive bile duct or gallbladder cancer."@en ;
  schema:url <https://onco.cc/trials/trap-btc/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06178445> ;
  onco:status "active" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/gemcitabine-cisplatin/> .